The global pharmaceutical packaging market size was valued at USD 110.4 billion in 2021 and is projected to reach USD 243.7 billion by 2030 at a CAGR of 9.2% from 2022 to 2030.
Pharmaceutical packaging is used as an economical means for providing protection, presentation, information, convenience, and transportation until the product has been consumed. Over the last several decades, the pharmaceutical sector has been on the rise, owing to the considerable growth in the global population and various government healthcare initiatives. Improving healthcare accessibility has led to an increase in the consumption of medicines and tablets, thereby accelerating the market.
Companies involved in pharmaceutical packaging have engaged in product innovations such as manufacturing eco-friendly packaging solutions or producing attractive labels to boost the sales and use of their products. However, the stringent and dynamic nature of regulations related to the pharmaceutical sector is expected to create some restrictions, impeding the market growth.
|Market Size||USD 243.7 billion by 2030|
|Fastest Growing Market||Europe|
|Largest Market||North America|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends|
Emerging economies such as India, Brazil, among other similar economies, have been instrumental in the growth of the pharmaceutical industry. The sector is responsible for the development, manufacturing, and marketing of medications across the globe. It is estimated that the total revenue of the pharmaceutical industry is over USD one trillion. Notable companies such as Pfizer, Novartis, GlaxoSmithKline (GSK), have been actively investing significant capital into research and development of new and better drugs. For instance, as per the International Federation of Pharmaceutical Manufacturers & Association, the research divisions of the pharmaceutical sector spend around USD 149.8 billion per year. Global spending on medicines is anticipated to reach USD 1,460 billion by the year 2021, and the graph will only go upwards. The increased spending is attributed to the market expansion of pharmaceutical companies in emerging economies.
There has been, however, an increase in the number of counterfeit pharmaceutical products. For instance, in the year 2017, the Interpol seized potentially dangerous medicines worth USD 51 million. This exhibits a genuine threat as fake medicines can be packaged as something similar to a real pharmaceutical drug to earn higher profits in the black market. Companies involved in pharmaceutical packaging are focussing on designing packaging material so that it will be easy to distinguish fake products from genuine medicines.
Around 8% of the total global population is older than 65 years of age. The older population is prone to more diseases, which will increase the demand for premium drugs. Branded or premium drugs are more expensive as they are volatile to light and other external factors and require special packaging, which will lead to the market growth. Moreover, over half the global population falls in the working-age of 25 to 65 years. The working population is anticipated to consume drugs that cater to health and wellness segment. This will witness dominance and growth of over the counter (OTC) drugs which are available in tablets and jars and is likely to drive the market for packaged medicine during the forecast period.
Europe’s demographic shows that the region has a large the older population, owing to the lower fertility rates and higher life expectancy. Europe saw industrial development earlier than most other regions, allowing it to witness economic progress before the world reaped it. The high economic gains by this region saw Europe focussing more on improving the healthcare system and focussing on the research of medicines. An improved lifestyle and a robust healthcare system together have contributed to the longevity of its population which now has resulted in an increased number of the population who are above the age of 60. The dominance of Europe in this market will majorly be due to economies in Western Europe.
The U.S. is anticipated to have the highest share in the North America pharmaceutical packaging market as the country is the largest pharmaceutical market in the world. Furthermore, the presence of a slew of pharmaceutical companies is likely to provide an impetus to the market. These companies are actively working towards new drug development and are advancing in technologies such as biologics and nanomedicines, which will result in the pharmaceutical packaging market growth in North America.
Based on type, the market is segmented into cartridges, blister packs, labels and accessories, caps and closures, plastic bottles, pre-fillable syringes, temperature-controlled packaging, pre-filled inhalers, medical specialty bags, pouches and strip packs, vials, ampoules, jars and canisters, and medication tubes. The pre-fillable syringes segment is expected to hold the dominant share during the forecast period. They aid in reducing wastage and are also patient compliant by presenting self-administered metered dosages.
An active lifestyle, combined with high healthcare costs in emerging economies have driven patients to seek drugs that would aid in, not only saving time but also enabling them to avoid going to clinics and hospitals. These trends will lead towards higher demand for pre-fillable syringes, especially from patients who have a history or are currently battling illnesses such as diabetes and use self-administering.
Based on product type, it is divided into primary, secondary, and tertiary packaging. The primary packaging segment is the packaging that comes first in terms of coming in contact with the medicine. The constant temperature fluctuations and other disturbances while transporting medicines are likely to accelerate the primary packaging segment growth during the forecast period.
The plastics and polymers segment is expected to dominate the market, owing to the easy availability of raw materials to manufacture the final product. The paper and paperboards segment is expected to register the highest growth rate during the forecast period, while the oral drugs segment is anticipated to have the highest growth rate in the drug delivery mode segment.
Prominent players are focusing on acquisitions and mergers to avoid dominance or market capture by smaller companies. For instance, in July 2019, RPC Group PLC was acquired by Berry Global. The RPC Group PLC is among the significant providers of rigid packaging to various industries such as healthcare, food and beverage, and other industrial end-users. In June 2019, Bernis, one of the prominent players in flexible packaging, was acquired by Amcor. This is likely to make it possible for Amcor to cater to its expanding customer base and is expected to strengthen its position in an already competitive market.
Companies are adopting an array of organic and inorganic growth strategies. Product development and innovation, partnerships, and investing substantially in research and development are some of the strategies the companies are adopting and will continue to do so in the near future.